Austrian company Inte:Ligand, which specializes in the development
of new drugs by computer simulation has launched a new software
package for modern drug design, which will provide pharma companies
with a tool to speed up the entire...
A new generation of 'smart antibiotics', which uses a virus that
adapts to recognize and attack bacteria, could become the latest
approach to tackling the growing public health problem of
antibiotic-resistant pathogens such...
Antibody technology company MorphoSys has formed a marketing
collaboration with Genefrontier, with a view to accessing the
Japanese life science market. This agreement will aim to establish
MorphoSys' HuCAL technology in the...
Denmark's DakoCytomation has started shipping a new flow cytometry
instrument for use in the analysis of cells in disease research
that is smaller than any other product in the class, and is claimed
to be the fastest system on...
Researchers at the University of Rochester Medical Center, using GE
Healthcare's CodeLink microarrays, have identified key changes in
gene expression that provide an improved understanding of the
malfunction and death of the...
Scientists in the US have developed Textpresso, a new text-mining
system for scientific literature which implements a unique search
engine using 33 catagories of terms for which a database of
articles and individual sentences can...
Key changes discovered in gene expression that provide an improved
understanding of neurones controlling movement and coordination and
their malfunction and death in Parkinson's Disease has lead to the
possibility of a drug therapy...
Labelling giant Avery Dennison has formed a new business unit to
manufacture and sell low-cost radiofrequency identification (RFID)
inlays and tags, putting its weight behind a technology that to
date has mostly been pushed forward...
In contrast to conventional wisdom, stirring a mix of granular
ingredients faster or longer in the manufacturing of
pharmaceuticals is not the key to getting a smooth blend.
Drug giant Pfizer is planning to buy UK-based drug delivery company
Meridica in a move that it says will bolster its activities in
allergy and respiratory medicine.
Researchers at Staffordshire University in the UK have come up with
a new robotic arm that is fully mobile, has accuracy that rivals
industrial fixed robot arms and could cost significantly less.
Curvaceous Software will showcase its recently launched process
analytical technology (PAT) package at next week's World Pharma IT
congress in London, UK.
Switzerland's Serono, Europe's largest biotechnology company, has
said it will close its InterPharm manufacturing plant in Ness
Ziona, Israel, by the end of year.
German biotechnological company SIRS-Lab, has introduced the
Lab-Arraytor 60-inflammation, a biochip that comprises a total of
780 inflammation-defined genes, specifically to understand the
molecular framework of acute inflammatory...
A drug delivery device worn like a wristwatch and programmed to
administer doses automatically has been developed by Chrono
Therapeutics and researchers at the University of Basel in
Switzerland.
French drug delivery specialist Novagali has raised €14 million in
a second round of fundraising and says the cash will allow it to
support its development programmes, based on a proprietary emulsion
technology, for up to three years.
Australia's Boron Molecular has set up a US agent, Boron Molecular
that aims to promote and increase the sale and distribution of the
company's range of organoboron compounds throughout the US market.
The results of an ongoing study could revolutionise Alzheimer's
disease treatment as a new technique, which uses a gene therapy
agent to deliver a drug containing nerve growth factor (NGF), to
the brain area affected by Alzheimer's...
Polymer Laboratories has launched a range of capillary and micro
chromatography columns for small scale chromatography which use
chemically stable polymeric particles to suit demanding high
sensitivity separations in drug discovery...
An experimental drug that block signals promoting uncontrolled
growth of blood cells, characteristic of Myeloproliferative Disease
(MPD) reported improvement in a sufferer's symptoms raising the
possibility of an effective cancer...
Inyx has acquired a Swiss-developed drug delivery technology that
should make it possible to develop inhaled drug therapies with two
or more active compounds, even if they are incompatible or
unstable.
Constant innovation in the field of microfluidics and uTAS has
enabled lab-on-a-chip (LOC) technologies to successfully enter the
mainstream commercial market especially impacting on
high-throughput screening of drug candidates, point...
Solvay subsidiary Peptisyntha is boosting its capacity to make
peptides at its facilities in California, US, in anticipation of
increasing numbers of drugs in this class coming through to market.
Kyowa Hakko Kogyo has developed a new process for manufacturing
amino acid dimers - also known as di-peptides - that could increase
their use as components in infusions and enteral nutrition
products.
Freeman Technology is gearing up to launch the first in a new range
of accessories for its FT4 powder rheometer that are designed to
bring it into the age of industrial automation.
Drug major Roche has licensed a technology developed by Glycart
Biotechnology that makes antibody-based drugs more effective by
making them resemble natural human antibodies more closely.
Medarex has announced a global collaboration agreement with Pfizer
that will provide for the discovery and development of up to 50
antibody products over ten years including the creation of fully
human antibody products in a variety...
The world's leading pharmaceutical companies are not doing enough
to help improve the health of countries in the third world. They
will also be completely unprepared to face the increasing demand
for drugs for diseases other...
Cancer therapy specialists, Ziopharm, has announced it has entered
into a licensing agreement for a new class of organic arsenicals
with the intention of developing them for a wide range of cancers
Cellomics has launched a new image analysis software module that
allows scientists performing drug discovery and basic science
research to analyse a broad variety of cell-based assays in as
little as five minutes.
News that B-MS has dropped out of an agreement to develop Basulin,
an improved formulation of insulin which was the subject of a $165
million deal - including $20 million upfront - between the two
companies last year.
A study, which uses immunoglobulins to treat multiple sclerosis,
may also be able to help patients with Alzheimer's. The discovery
seems to point towards an approach, which treats Alzheimer's with
anti-bodies, which are...
Rhodia Pharma Solutions is reducing the workforce at its Dudley
site in the UK by up to 85 jobs in a continuing shake-up of the
company's custom manufacturing and intermediates business.
Austrian biotech company, Austrianova, has received approval from
the European Medicines Evaluation Agency (EMEA) for its product
Novacaps, a new category of therapeutic for pancreatic cancer.
EMEA's latest decision ensures trial...
New research in the US, focusing on the pharmacological aspects of
smoking marijuana, are closer to understanding how the drugs active
ingredients exert its effects, paving the way for drugs that
selectively bind and block subtypes...
Cellomics has launched a new image analysis software module that
allows scientists performing drug discovery and basic science
research to analyse a broad variety of cell-based assays in as
little as five minutes.
A 'tail' at one end of the Ubc 12 protein has been found to
play a key role in accelerating cell replication. The determination
of its structure and role bodes well for the development of new
types of drugs targeting the...
Hoerbiger-Origa of Germany, which specialises in automation systems
of industrial applications, has launched a new modular belt-driven
linear actuator for heavy-duty applications that will compete with
rack and pinion drives.
The lead agent in a new class of drugs for the treatment of
diabetes - Novartis' LAF-237 - seems to improve glucose control
without the weight gain associated with other orally-active drugs
for this common disease, reports Phil...
Videojet Technologies has developed the Videojet Broadcast System
as a cost effective means of helping suppliers meet tight retailer
mandates on RFID implementation.
The Generic Pharmaceutical Association (GPhA) has urged the US Food
and Drug Administration (FDA) to move forward to accelerate the
approval of affordable generic versions of biopharmaceutical drugs.
Agilent has released a new module for its ChemStation Plus CDS
(chromatography data plus) software that falls into compliance with
internationally agreed guidelines on short- and long-term stability
studies.
Rumours of the demise of Ireland as a hotbed of pharmaceutical
manufacturing may be premature. Pfizer has just unveiled a plan to
spend €240 million to expand its Dun Laoghaire plant in Dublin.
UK drug delivery company SkyePharma has reported net losses down in
the first half of the year, but warned revenues and cash flow will
come under pressure as it moves away from its current
milestone-based revenue model.
The first molecular-scale images of DNA binding to an adenovirus
enzyme, a crucial step for a virus to cause infection, have been
produced, which shows how binding to DNA may stimulate the enzyme,
aiding to the design of new antiviral...
Accelrys has signed a $21.5 million (€17.6 million) agreement to
merge SciTegic with one of its subsidiaries in a deal that will add
additional data analysis and mining software design capabilities to
Accelrys' extensive portfolio...
Cambrex Corporation announces the availability of a method for the
non-cytotoxic delivery of biologically active cargo molecules, such
as proteins, peptides, or small molecules directly into living
cells providing drug R&D with...
GE's security business has begun testing a cost-effective container
security solution for use in maritime shipping. The new product is
designed to detect unauthorised access to a container, and can
monitor the container in transit...
